Structural differences among monoclonal antibodies with distinct fine specificities and kinetic properties. 1999

T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
Department of Zoology, University of Maryland, College Park, MD USA.

The mAbs HyHEL-8, HyHEL-26 (HH8, and HH26, respectively) recognize epitopes on hen egg-white lysozyme (HEL) highly overlapping with the structurally defined HH10 epitope, while the structurally related XRPC-25 is specific for DNP and does not bind HEL. All four Abs appear to use the same Vk23 germ line gene, and all but HH8 use the same VH36-60 germ line gene. Of the three anti-HEL Abs, the sequences of HH26 variable regions are closest to those encoded by the respective germ line sequences. HH8 utilizes a different member of the VH36-60 gene family. Thus, the same Vk and VH genes, combined with somatically derived sequence differences, are used to recognize the unrelated Ags HEL and DNP. In contrast, different VH36-60 germ line genes are used to bind the same antigen (e.g. HH8 vs HH10 and HH26). While the affinities of HH10, HH8, and HH26 for HEL vary by less than 10-fold, their affinities for mutated Ag vary over several orders of magnitude. Analyses of Fab binding kinetics with natural species variants and site-directed mutants of lysozyme indicate that these cross-reactivity differences reflect the relative sensitivities of both the association and dissociation rates to antigenic mutation: HH8 has relatively mutation-insensitive association and dissociation rates, HH10 has a relatively mutation-sensitive association rate but more variable dissociation rates, and HH26 has variable association and dissociation rates. Only a few amino acid differences among the antibodies produce the observed differences in the robustness of the association and dissociation rates. Our results suggest that association and dissociation rates and mutation sensitivity of these rates may be independently modulated during antibody repertoire development.

UI MeSH Term Description Entries
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000915 Antibody Affinity A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Affinity, Antibody,Antibody Avidity,Avidity, Antibody,Affinities, Antibody,Antibody Affinities,Antibody Avidities,Avidities, Antibody
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody

Related Publications

T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
November 1961, Proceedings of the National Academy of Sciences of the United States of America,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
January 1988, International archives of allergy and applied immunology,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
June 1999, Transfusion medicine (Oxford, England),
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
April 1985, Clinical and experimental immunology,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
June 1996, The Journal of investigative dermatology,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
April 1988, Journal of biochemistry,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
December 1992, Hybridoma,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
January 1986, Biomedica biochimica acta,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
November 1987, Molecular immunology,
T B Lavoie, and S Mohan, and C A Lipschultz, and J C Grivel, and Y Li, and C R Mainhart, and L N Kam-Morgan, and W N Drohan, and S J Smith-Gill
April 1986, Molecular immunology,
Copied contents to your clipboard!